Subscribe to posts

Monday, 25 March 2013

Breast cancer survivors who cut short preventative treatment 'risk early death'

Women who stop taking tamoxifen tablets to prevent breast cancer returning before the end of the recommended 5 years risk an earlier death, according to research.

A study carried out on nearly 3,400 women in Tayside, Scotland, found that only half who had been given tamoxifen, or one of a class of newer antihormone drugs called aromatase inhibitors, after breast cancer treatment were still taking the pills at the end of 5 years. Some had stopped; others reduced the dose. Those who had given up after three years were 3 times more likely to die of breast cancer, during the follow-up period of the study, than those who took the pills for 80% of the time for all 5 years.

No comments: